Abstract
Gloriosa superba: L. (G. superba) is a perennial creeper and climbs up to 5-7 meters. It belongs to the Liliaceae family and is native to Africa and South-East Asia. It is also categorized as an endangered plant which may be due to its extensive use.
Objective: The objective of the present review is to explore anticancer potential with other pharmacological activities of G. superba and its active constituents.
Results: G. superba has been reported to have many chemical constituents including colchicine, β- sitosterol, glumicolchicine, b-lumicolchicine, 2-OH-6-MeO-benzoic acid, glorisine, tannins, colchicoside, cornigerine, and many more. Most of them are effective against cancer, gout, arthritis, ulcers, bleeding piles, impotence, snakebites, skin diseases, and leprosy. G. superba has also been reported to possess pharmacological activities like anticancer, anti-inflammatory, antioxidant, abortifacient, anti-ulcerogenic, anti-helminthic and antimicrobial.
Conclusion: The present review summarizes the anticancer potential of G. superba and its constituents. However, a detailed study is required to establish it as an effective anticancer drug.
Keywords: Gloriosa superba l., anticancer, colchicine, anti-inflammatory, colchicoside, conigerine.
Graphical Abstract
The Natural Products Journal
Title:A Retrospective Study on Gloriosa superba and Its Main Active Constituents
Volume: 11 Issue: 4
Author(s): Aishwarya Shriwastava, Vijay Chopra, Manish Vyas*, Gopal L. Khatik, Pramod Yadav, Jeena Gupta and Amrit Pal Singh
Affiliation:
- Department of Ayurveda, School of Pharmaceutical Sciences, Lovely Professional University, Phagwara,India
Keywords: Gloriosa superba l., anticancer, colchicine, anti-inflammatory, colchicoside, conigerine.
Abstract:
Gloriosa superba: L. (G. superba) is a perennial creeper and climbs up to 5-7 meters. It belongs to the Liliaceae family and is native to Africa and South-East Asia. It is also categorized as an endangered plant which may be due to its extensive use.
Objective: The objective of the present review is to explore anticancer potential with other pharmacological activities of G. superba and its active constituents.
Results: G. superba has been reported to have many chemical constituents including colchicine, β- sitosterol, glumicolchicine, b-lumicolchicine, 2-OH-6-MeO-benzoic acid, glorisine, tannins, colchicoside, cornigerine, and many more. Most of them are effective against cancer, gout, arthritis, ulcers, bleeding piles, impotence, snakebites, skin diseases, and leprosy. G. superba has also been reported to possess pharmacological activities like anticancer, anti-inflammatory, antioxidant, abortifacient, anti-ulcerogenic, anti-helminthic and antimicrobial.
Conclusion: The present review summarizes the anticancer potential of G. superba and its constituents. However, a detailed study is required to establish it as an effective anticancer drug.
Export Options
About this article
Cite this article as:
Shriwastava Aishwarya, Chopra Vijay , Vyas Manish *, Khatik L. Gopal , Yadav Pramod , Gupta Jeena and Singh Pal Amrit , A Retrospective Study on Gloriosa superba and Its Main Active Constituents, The Natural Products Journal 2021; 11 (4) . https://dx.doi.org/10.2174/2210315510999200704141949
DOI https://dx.doi.org/10.2174/2210315510999200704141949 |
Print ISSN 2210-3155 |
Publisher Name Bentham Science Publisher |
Online ISSN 2210-3163 |
![](/images/wayfinder.jpg)
- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
A Review of the Chemical and Pharmacological Aspects of the Genus Marrubium
Current Pharmaceutical Design Stathmin, Interacting with Nf-κB, Promotes Tumor Growth and Predicts Poor Prognosis of Pancreatic Cancer
Current Molecular Medicine Bugs as Drugs: Understanding the Linkage between Gut Microbiota and Cancer Treatment
Current Drug Targets What Makes Y Family Pols Potential Candidates for Molecular Targeted Therapies and Novel Biotechnological Applications
Current Molecular Medicine microRNAs, Gap Junctional Intercellular Communication and Mesenchymal Stem Cells in Breast Cancer Metastasis
Current Cancer Therapy Reviews Targeting Tumor Ubiquitin-Proteasome Pathway with Polyphenols for Chemosensitization
Anti-Cancer Agents in Medicinal Chemistry Crystallization and X-Ray Data Analysis of the Extended Dna-Binding Domain of the E2 Bovine Papillomavirus Type 1 Protein
Protein & Peptide Letters Effective Prodrug Liposome and Conversion to Active Metabolite
Current Drug Metabolism Namitecan: a Hydrophilic Camptothecin with a Promising Preclinical Profile
Current Medicinal Chemistry Recent Development in Targeting PI3K-Akt-mTOR Signaling for Anticancer Therapeutic Strategies
Anti-Cancer Agents in Medicinal Chemistry Chemical Constituents and Cytotoxicity of Euphorbia vajravelui
Letters in Organic Chemistry Solvent-free Synthesis and Antimicrobial Properties of Some Novel Furanone and Spiropyrimidone Derivatives
Current Organic Synthesis HPV Viral Activity by mRNA-HPV Molecular Analysis to Screen the Transforming Infections in Precancer Cervical Lesions
Current Pharmaceutical Biotechnology 2',6'-dihydroxy-4'-methoxy Dihydrochalcone Improves the Cognitive Impairment of Alzheimer's Disease: A Structure-activity Relationship Study
Current Topics in Medicinal Chemistry From Natural Products to Small Molecule Ketone Histone Deacetylase Inhibitors: Development of New Class Specific Agents
Current Pharmaceutical Design Baicalin-induced Cytotoxicity and Apoptosis in Multidrug-resistant MC3/5FU Mucoepidermoid Carcinoma Cell Line
Letters in Drug Design & Discovery From Bortezomib to other Inhibitors of the Proteasome and Beyond
Current Pharmaceutical Design Overview of SLC22A and SLCO Families of Drug Uptake Transporters in the Context of Cancer Treatments
Current Drug Metabolism Combination of DC Vaccine and Conventional Chemotherapeutics
Anti-Cancer Agents in Medicinal Chemistry Human Papilloma Virus Vaccine Associated Uveitis
Current Drug Safety